scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1399-5618.2011.00908.X |
P698 | PubMed publication ID | 21443568 |
P50 | author | Iria Grande | Q56223794 |
Marc Valentí | Q56949369 | ||
Adriane R Rosa | Q57623776 | ||
Isabella Pacchiarotti | Q99232984 | ||
Dina Popovic | Q99596464 | ||
Alessandra M A Nivoli | Q117224679 | ||
Andrea Murru | Q42839770 | ||
Francesc Colom | Q45741583 | ||
Eduard Vieta | Q20090640 | ||
P2093 | author name string | C Mar Bonnín | |
P2860 | cites work | Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. | Q50929769 |
Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. | Q51053741 | ||
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. | Q51899995 | ||
Relevance of the catatonic syndrome to the mixed manic episode | Q51948867 | ||
Diagnosis and treatment of mixed mania. | Q54413597 | ||
Why Do Clinicians Maintain Antidepressants in Some Patients With Acute Mania? | Q57612596 | ||
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. | Q43867164 | ||
Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants | Q46055681 | ||
Prevalence of mixed mania using 3 definitions | Q46120264 | ||
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers | Q46921505 | ||
A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder | Q48945785 | ||
Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors | Q50086401 | ||
Secular trends in first hospitalizations for major mood disorders with comorbid substance use. | Q50773310 | ||
A rating scale for depression | Q24564540 | ||
Effectiveness of adjunctive antidepressant treatment for bipolar depression | Q28295408 | ||
A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
Mixed affective disorders | Q30319923 | ||
A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. | Q30884720 | ||
The role of gender in mixed mania | Q33878237 | ||
Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale | Q34153705 | ||
Antidepressants for bipolar depression: a systematic review of randomized, controlled trials | Q34344394 | ||
Gender differences in bipolar disorder | Q35561522 | ||
Pharmacotherapy of bipolar mixed states | Q36130303 | ||
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies | Q36161335 | ||
Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression | Q36168806 | ||
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders | Q37558582 | ||
The prevalence of mixed episodes during the course of illness in bipolar disorder | Q40128111 | ||
Suicidality in patients with pure and depressive mania | Q40692924 | ||
Antidepressant-induced mania and cycle acceleration: a controversy revisited | Q40977115 | ||
P433 | issue | 2 | |
P921 | main subject | bipolar I disorder | Q4915474 |
P304 | page(s) | 145-154 | |
P577 | publication date | 2011-03-01 | |
P1433 | published in | Bipolar Disorders | Q15716681 |
P1476 | title | Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients | |
P478 | volume | 13 |
Q35073872 | Antimanic treatments in bipolar mixed states |
Q37951106 | Bipolar disorder differences between genders: special considerations for women |
Q38211511 | Clinical decision making in the treatment of mixed states |
Q44406357 | Clinical description of mixed mania |
Q43618621 | Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd). |
Q28077687 | Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview |
Q34504587 | Evaluating depressive symptoms in hypomanic and manic episodes using a structured diagnostic tool: validation of a new Mini International Neuropsychiatric Interview (M.I.N.I.) module for the DSM-5 'With Mixed Features' specifier |
Q35586518 | Evaluating depressive symptoms in mania: a naturalistic study of patients with bipolar disorder |
Q45741858 | Lipophilic statin use and suicidal ideation in a sample of adults with mood disorders |
Q48083750 | Making sense of DSM-5 mania with depressive features |
Q47841607 | Mixed features in bipolar disorder |
Q45771100 | Patterns of pharmacological maintenance treatment in a community mental health services bipolar disorder cohort study (SIN-DEPRES). |
Q34349641 | Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis |
Q26824365 | Review of evidence for use of antidepressants in bipolar depression |
Q35862776 | Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders |
Q37234668 | Suicidality and symptoms of anxiety, irritability, and agitation in patients experiencing manic episodes with depressive symptoms: a naturalistic study |
Q30583384 | The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders |
Q26783934 | The State of the Art of the DSM-5 "with Mixed Features" Specifier |
Q38040453 | The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states? |
Q35119891 | The complexity of "mixed" depression: a common clinical presentation |
Q38093728 | Use of asenapine in clinical practice for the management of bipolar mania |
Q88086377 | Weighing the Risks: the Management of Bipolar Disorder During Pregnancy |
Search more.